SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene - PubMed (original) (raw)
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
J A DeCaprio et al. Cell. 1988.
Abstract
Monkey cells synthesizing SV40 large T antigen were lysed and the extracts immunoprecipitated with either monoclonal anti-T antibody or monoclonal antibody to p110-114, the product of the retinoblastoma susceptibility gene (Rb). T and p110-114 coprecipitated in each case, implying that the proteins are complexed with each other. Substitution and internal deletion mutants of T that contain structural alterations in a ten residue, transformation-controlling domain failed to complex with p110-114. In contrast, T mutants bearing structural changes outside of this domain bound to p110-114. These results are consistent with a model for transformation by SV40 which, at least in part, involves T/p110-114 complex formation and the perturbation of Rb protein and/or T function.
Similar articles
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.
Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA. Ludlow JW, et al. Cell. 1990 Feb 9;60(3):387-96. doi: 10.1016/0092-8674(90)90590-b. Cell. 1990. PMID: 2154332 - Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.
Tan TH, Wallis J, Levine AJ. Tan TH, et al. J Virol. 1986 Sep;59(3):574-83. doi: 10.1128/JVI.59.3.574-583.1986. J Virol. 1986. PMID: 3016321 Free PMC article. - SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family.
Ludlow JW, DeCaprio JA, Huang CM, Lee WH, Paucha E, Livingston DM. Ludlow JW, et al. Cell. 1989 Jan 13;56(1):57-65. doi: 10.1016/0092-8674(89)90983-5. Cell. 1989. PMID: 2910497 - RB and the cell cycle: entrance or exit?
Cooper JA, Whyte P. Cooper JA, et al. Cell. 1989 Sep 22;58(6):1009-11. doi: 10.1016/0092-8674(89)90495-9. Cell. 1989. PMID: 2673538 Review. No abstract available. - Immunohistochemistry of retinoblastoma. A review.
Donoso LA, Shields CL, Lee EY. Donoso LA, et al. Ophthalmic Paediatr Genet. 1989 Mar;10(1):3-32. doi: 10.3109/13816818909083770. Ophthalmic Paediatr Genet. 1989. PMID: 2662094 Review.
Cited by
- Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y, Wong JH, Jha HC, Tian T, Wei Z, Robertson ES. Pei Y, et al. J Virol. 2020 Oct 27;94(22):e01209-20. doi: 10.1128/JVI.01209-20. Print 2020 Oct 27. J Virol. 2020. PMID: 32847849 Free PMC article. - Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression.
Stacy T, Chamberlain M, Cole CN. Stacy T, et al. J Virol. 1989 Dec;63(12):5208-15. doi: 10.1128/JVI.63.12.5208-5215.1989. J Virol. 1989. PMID: 2555552 Free PMC article. - Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation.
Templeton DJ. Templeton DJ. Mol Cell Biol. 1992 Feb;12(2):435-43. doi: 10.1128/mcb.12.2.435-443.1992. Mol Cell Biol. 1992. PMID: 1310146 Free PMC article. - Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
Scheffner M, Münger K, Huibregtse JM, Howley PM. Scheffner M, et al. EMBO J. 1992 Jul;11(7):2425-31. doi: 10.1002/j.1460-2075.1992.tb05307.x. EMBO J. 1992. PMID: 1321031 Free PMC article. - Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
Cohen JI, Wang F, Kieff E. Cohen JI, et al. J Virol. 1991 May;65(5):2545-54. doi: 10.1128/JVI.65.5.2545-2554.1991. J Virol. 1991. PMID: 1850028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases